Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Last €62.26 EUR
Change Today +3.07 / 5.18%
Volume 0.0
0MJA On Other Exchanges
As of 11:02 AM 02/10/16 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

2701 Patriot Boulevard

Fourth Floor

Glenview, IL 60026

United States

Phone: 847-832-2420


Mead Johnson Nutrition Company manufactures, distributes, and sells infant formula, children’s nutrition, and other nutritional products. The company’s product portfolio addresses a range of nutritional needs for infants, children, and expectant and nursing mothers. Product Portfolio The company’s product portfolio, which addresses a range of pediatric nutritional needs, consists of two principal product categories, such as infant formula and children’s nutrition. These product categories could be separated into five general product types, such as routine infant, solutions, specialty, children’s nutrition, and other. The company’s routine infant formula is intended for healthy consumers while its solutions and specialty products are offered for infants with special nutritional needs. The company’s children’s nutrition products are designed to meet the nutritional needs of children at different stages of development. The company’s other products include vitamins and supplements. It markets products under different names in various regions worldwide. Routine Infant Formula: The company designs routine infant formula as a breast milk substitute for healthy, full-term infants without special nutritional needs both for the use as the infant’s sole source of nutrition and as a supplement to breastfeeding. The company’s routine infant formulas have four major components, such as protein from cow’s milk that is processed to have a profile similar to human milk; a blend of vegetable fats (including docosahexaenoic acid and arachidonic acid) to replace bovine milk fat to resemble the composition of human milk; a carbohydrate, generally lactose from cow’s milk; and a vitamin and mineral ‘micronutrient’ pre-mix that is blended into the product to meet the specific needs of the infant at a given age. The company’s major routine infant formula products include Enfamil Premium, Enfapro Premium, Enfamil A+, and Enfalac A+. Solutions Products: The company designs various solutions formulas to address common feeding tolerance problems, including spit-up, fussiness, gas and lactose intolerance. The company’s primary solutions products include Enfamil Gentlease (for fussiness and gas), Enfamil A.R. (to reduce spit-up), Enfamil ProSobee (a soy-based formula), and Enfamil LactoFree (for lactose intolerance). Specialty Products: The company designs specialty formulas to address certain conditions or special medical needs, including Nutramigen (for cow’s milk protein allergies) and Puramino (an amino acid formula for severe cow’s milk protein allergies or multiple other food allergies). The company designs products, such as Enfamil Premature to meet the needs of premature and low birth weight infants under the supervision of a doctor, often in the hospital; and EnfaCare, a hypercaloric formula for premature babies at home. The company also produces medical foods, or foods for special medical purposes, for nutritional management of individuals with rare, inborn errors of metabolism, such as maple syrup urine disease (Mead Johnson BCAD) and phenylketonuria (Mead Johnson Phenyl-Free). Certain of these products are intended for infants and young children while others are suitable for children and adults. Children’s Nutrition Products: The company designs its children’s products to meet the changing nutritional needs of children at different stages of development (toddlers and older children). The company’s primary children’s nutrition products include Enfagrow, Sustagen, and Lactum. These products are not breast milk substitutes and are not designed as a sole source of nutrition but instead are designed to be a part of a child’s appropriate diet. The company also offers ‘milk modifiers’ (ChocoMilk and Cal-C-Tose) that, when added to a glass of milk, improve the milk’s nutritional value. Other Products: The company also produces a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers, including Expecta and EnfaMama. The company’s pediatric vitamin products sold in some geographies, such as Enfamil Poly-Vi-Sol, provide a range of benefits for infants, including multivitamins and iron supplements. Sales and Marketing The company markets its portfolio of approximately 70 products to mothers, health care professionals, and retailers in approximately 50 countries in North America, Europe, Asia, and Latin America. Its products are marketed worldwide through its global sales and marketing efforts. The company’s sales force markets its products to each of the retail channels where its products are purchased by consumers, including mass merchandisers, club stores, baby stores, grocery stores, drug stores, and to a limited extent, convenience stores. In North America, Eastern Europe, Latin America and Asia, the company focuses on all retail channels. In Western Europe, the company focuses primarily on specialty products sold through pharmacies. The company has logistics partnerships with distributors in majority of its markets. Customers The company’s products are sold principally to distributors and retail customers, both nationally and internationally. Sales to two of its customers, DKSH International Ltd., a distributor serving primarily Asia (including sales to its regional affiliates); and Wal-Mart Stores, Inc. (including sales to Sam’s Club), accounted for approximately 16% and 11% of the company’s gross sales for the year ended December 31, 2014. Research and Development The company’s research and development expense was $115.1 million in the year ended December 31, 2014. Intellectual Property Patents: The company owned or licensed approximately 67 active U.S. patents and 450 active non-U.S. patents, and had 106 pending U.S. patent applications and 853 pending non-U.S. patent applications as of December 31, 2014. Trademarks: The company maintains approximately 6,900 trademark registrations and applications in approximately 100 countries worldwide. Competition The company’s major global competitors are Abbott Laboratories, Danone, and Nestlé S.A. History Mead Johnson Nutrition Company was founded in 1905.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
0MJA:GR €62.26 EUR +3.07

0MJA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biostime International Holdings Ltd $21.65 HKD -1.25
Inner Mongolia Yili Industrial Group Co Ltd CNY13.36 CNY -0.09
Perrigo Co PLC $137.46 USD -1.31
Hain Celestial Group Inc/The $34.28 USD +0.15
Yakult Honsha Co Ltd ¥5,440 JPY -40.00
View Industry Companies

Industry Analysis


Industry Average

Valuation 0MJA Industry Range
Price/Earnings 20.8x
Price/Sales 3.2x
Price/Book NM Not Meaningful
Price/Cash Flow 20.6x
TEV/Sales 2.1x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MEAD JOHNSON NUTRITION CO, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at